Clinical description GB1
Supplementary Figure 2:
Calculated ratios between cfDNA and basepair-peaks using the formula: cfDNA/(bppeak/100) 2 for patients GB1-8. A trend towards a smaller ratio was seen in majority of samples during radiotherapy/Temozolomide as compared to the adjuvant setting. A smaller ratio was again seen in the two patients with complications; GB2 at time of meningitis and GB7 at time of intracerebral bleeding which took place during the sixth cycle of adjuvant treatment. The lesser ratio could illustrate a smaller fraction of ctDNA in the total cfDNA in these samples. 
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